FDA Brief

Warning letters Food

FDA warning letter to

Rama Food Manufacture Corp.

High riskIssued Sep 22Posted Oct 27Human Foods Program

FDA warns Rama Food Manufacture after inspections found insanitary conditions and preventive-control failures at its California ready-to-eat rice noodle plants.

What happened

FDA inspected two Ontario, California facilities from January 27 through February 26, 2026. It found failures in required food-safety manufacturing and preventive controls, Listeria spp. on environmental swabs (not the human-pathogenic species), finished-product pH and water activity results outside the firm’s targets, and time-temperature abuse of ready-to-eat rice noodles. FDA said the noodles were adulterated—prepared, packed, or held under insanitary conditions.

What FDA found

  1. At the E Cedar Street facility, written process preventive controls for pathogens such as Bacillus cereus, Salmonella, Listeria monocytogenes, and Clostridium botulinum had critical limits, monitoring, or controls that were inadequate or not met.

    21 CFR 117.135(c)(1)
  2. At the E Cedar Street facility, sanitation controls were inadequate because food-contact equipment was cleaned only on a rotating basis and some direct-contact sheets were not cleaned and had discoloration or frayed edges.

    21 CFR 117.135(c)(3)
  3. At the S Parco Avenue facility, the firm did not prepare or implement a food safety plan containing the required hazard analysis, preventive controls, supply-chain program, recall plan, monitoring, corrective-action, and verification procedures.

    21 CFR 117.126(a)(1)
  4. At the S Parco Avenue facility, the hazard analysis did not identify pathogen growth or recontamination with environmental pathogens as hazards requiring preventive controls for the refrigerated RTE rice noodles in ROP packaging.

    21 CFR 117.130(a); 21 CFR 117.135(a)(1)
  5. FDA found the RTE rice noodles were prepared, packed, or held under insanitary conditions whereby they may have become contaminated with filth or been rendered injurious to health.

    FD&C Act section 402(a)(4) [21 U.S.C. § 342(a)(4)]
  6. FDA found finished-product pH did not consistently meet the firm’s critical limit and storage temperatures allowed extended exposure above 40°F, which may allow pathogen growth or toxin formation.

    21 CFR 117.135(c)(1)

What FDA wants

FDA tells the company to correct the cited CGMP and preventive-control violations and says it will evaluate the adequacy of corrective actions during the next inspection; the provided excerpt does not state a response deadline.

Who should pay attention

  • retailers and distributors selling refrigerated ready-to-eat rice noodles
  • brands that buy RTE noodles from contract manufacturers
  • quality teams managing ROP and ready-to-eat noodle production

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. ABC Food Corp

    ABC Food Corp's ready-to-eat rice noodles and tofu were made without required hazard analysis and preventive controls.

    High risk
  2. IF Co-Pack, LLC dba Initiative Foods

    FDA warns Initiative Foods, a Sanger, California baby food maker, that it failed to control patulin, a mold toxin, in fruit pouches.

    High risk
  3. Lewis Sausage Company Inc.

    FDA found Salmonella and Listeria in contract-made pet food from Lewis Sausage and says its pathogen controls are inadequate.

    High risk
  4. Dreyer’s Grand Ice Cream, Inc.

    FDA warns Dreyer’s Grand Ice Cream over Listeria and sanitation failures in frozen RTE ice cream.

    High risk